FACULTY BIO

James E. Udelson, MD
Chief, Division of Cardiology
Tufts Medical Center
Tufts University School of Medicine
Boston, MA

James E. Udelson, MD is Chief of the Division of Cardiology, as well as Director of Nuclear Cardiology, at Tufts Medical Center/Tufts University School of Medicine in Boston. Dr. Udelson's research interests involve studying the effects of new therapeutic modalities in the settings of heart failure and chronic coronary artery disease, as well as studying the development of imaging modalities to assess those effects. He has been an Associate Editor for the American Heart Association's cardiovascular journal Circulation since 2004, and was appointed as the initial Editorin- Chief for the new journal Circulation: Heart Failure in 2008. He is on the editorial board and has served as a Guest-Editor for the Journal of the American College of Cardiology and the Journal of Nuclear Cardiology, and has served on the AHA/ACC/ASNC Radionuclide Imaging Guidelines writing Task Force. Dr. Udelson is Past-President of the American Society of Nuclear Cardiology, and was recently elected to a 5-year term serving on the Board of Trustees of the American College of Cardiology (ACC). He has chaired the ACC's Cardiovascular Imaging Committee, served on the ACC Publications Committee, and is beginning a term as Chair of the ACC Governance Committee. He has served as a member of the FDA Medical Imaging Drugs Advisory Panel, is an invited advisor to the FDA's Division of Medical Imaging and Hematology Products, and has been invited as an ad hoc member of the FDA's Cardiovascular and Renal Drugs Advisory Panel. He is a member of the Association of University Cardiologists and the Association of Professors of Cardiology. He has been the recipient of several NIH grants for studies of the use of cardiac imaging to better understand the physiology of left ventricular function and to favorably influence clinical decision making. He has directed and/or participated in numerous clinical trials on heart failure and cardiac imaging, focusing on the role of new therapies and how they effect remodeling, physiology, function, and outcomes. Locally, he has been named several times by Boston magazines as one of Boston's Best Doctors in cardiology.

Dr. Udelson has been PI of several federally funded trials, including "Myocardial Viability and Left Ventricular Remodeling in the Occluded Artery Trial" (RO1 HL075456-01, ancillary study to the NHLBI funded Occluded Artery Trial [OAT] examining the influence of infarct zone viability by radionuclide techniques on post-MI left ventricular remodeling at 40 international sites), and "Left Ventricular Function Core Laboratory for the IMMEDIATE Trial" ancillary study to the IMMEDIATE Trial, assessing the effect of immediate glucose-insulin-potassium given in ambulances and Emergency Departments for acute coronary syndromes. He has also been Co-PI of the "Assessment of Sestamibi Imaging in Emergency Department Chest Pain Patients" (Agency for Health Care Policy and Research/DHHS RO1-HS090110-01), a seven center, 2,500 patient randomized trial of an ED strategy incorporating perfusion imaging compared to a standard strategy in chest pain patients with non-diagnostic ECG's.

Return to previous page